HaiHe Biopharma closes RMB1.2b Series B led by Warburg Pincus

2020-07-27
|
Isiah Liu

HaiHe Biopharma closes RMB1.2b Series B led by Warburg Pincus

HaiHe Biopharma, a leading biotechnology company focused on the discovery and development of innovative oncology drugs, announced today the completion of its Series B round worth 1.2 billion yuan.


The round was led by Warburg Pincus, with participation from CMB International, Legend Capital, a fund under CICC Capital, Chaos Investment, Beijing Langzi Asiana Asset Management, Winfast Holding, SSIC Capital, as well as the company’s Series A round investors Biotrack Capital, Yingke PE, Atlas Venture Capital and CSPC.


The funds raised will primarily be used to accelerate the global development and product launch of HaiHe Biopharma's multiple new oncology drugs. CEC Capital acted as the sole financial advisor to the company in this round of financing.


Haihe Biopharma focuses on the discovery, development and commercialization of innovative anti-tumor drugs. With a management team led by an academician from the Chinese Academy of Engineering, Haihe has established a "biomarker-guided" precision medicine platform.


The company has established and completed a technologically advanced and standardized preclinical evaluation system for new drugs and a clinical research system, which is in line with international standards, covering drug development, CMC research, biomarker discovery and confirmation, medical strategic planning and clinical research.


It has created a new drug development system and product pipeline with overlapping advantages and international competitiveness.


The company currently has eight clinical-stage compounds and three preclinical compounds.


RELATED ARTICLES

Eugenlight Technologies closes Series A of RMB tens of millions
2020-09-13
|
PEVC , Semiconductor , Electroinic

BPassword closes angel round led by Eagle Fund
2020-09-13
|
PEVC , Blockchain

Microtera Semiconductor closes Series A with RMB tens of millions
2020-09-13
|
PEVC , Semiconductor

Vertex Ventures completes new fund raising of RMB three bln
2020-09-13
|
PEVC , Technology , Semiconductor

Xiaoyinghe closes seed round of two mln yuan
2020-09-12
|
PEVC , Internet

Tingyun closes Series C of RMB 400 mln
2020-09-12
|
PEVC

Vision Medicals closes RMB200m Series B led by CDH Investments
2020-08-14
|
PEVC , Medicine , Medical care

Exegenesis Bio pockets over USD20m in Series B round led by Legend Capital
2020-08-04
|
PEVC , Biology , Biotech

Thousand Oaks Biopharmaceuticals closes RMB450m Series B round
2020-07-28
|
Biotech , Pharmaceutical , PEVC

3DPTEK closes multimillion-yuan Series B round led by CICC Capital
2020-07-03
|
Manufacturing , PEVC , 3D printing
China SDG